NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

Mphasis Takes First Steps Towards AI-Driven Business Model

Mphasis, a leading global technology services company, has embarked on a significant transformation with the launch of its Enterprise Agency platform, Mphasis Tria. This platform marks the company's first steps towards a platform-led, outcome-based pricing model. The platform is expected to differentiate Mphasis from its peers by leveraging AI-driven productivity gains to drive larger strategic transformation deals. These deals are typically led by strong C-suite level client relationships.

The company will be closely monitoring several key metrics to track the success of Mphasis Tria, including platform ARR (currently in the low single digits), platform attach rate, and net retention rate. Notably, Mphasis has seen a significant rise in the share of fixed-price contracts, which has increased by 1,000 basis points year-over-year. Additionally, the company has achieved a substantial improvement in revenue and profitability per employee, with a 21% increase over the past two years. These developments signal a strategic pivot towards an AI-driven business model.

Outlook and Valuation

Read also: Treasury Yields Experience Largest Increase in Two Weeks Following Release of Labor Market Data

Our research team continues to value Mphasis at 20x its FY28E EPS of INR 131, resulting in a target price of INR 2,620. We maintain a BUY recommendation for the company based on its promising growth prospects and strategic transformation initiatives.

Investor Takeaway

ICICI Securities recommends buying Mphasis with a target price of Rs 2620.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.